Intellia Therapeutics Newsroom

RBC Capital Maintains Intellia Therapeutics(NTLA.US) With Buy Rating, Maintains Target Price $54

Futu NewsSep 19 19:33

Intellia Therapeutics (NTLA) Receives a Buy From RBC Capital

TipRanksSep 19 18:47

Intellia Therapeutics Analyst Ratings

BenzingaSep 18 04:58

Jones Trading Initiates Coverage On Intellia Therapeutics With Buy Rating, Announces Price Target of $41

BenzingaSep 18 04:58

JonesTrading Initiates Intellia Therapeutics(NTLA.US) With Buy Rating, Announces Target Price $41

Futu NewsSep 18 04:32

Stifel Maintains Intellia Therapeutics(NTLA.US) With Buy Rating, Cuts Target Price to $64

Futu NewsSep 12 03:31

Intellia Therapeutics Is Maintained at Buy by Stifel

Dow JonesSep 11 19:55

Truist Financial Maintains Intellia Therapeutics(NTLA.US) With Buy Rating

Futu NewsSep 3 19:31

Analysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA), Genmab (GMAB) and Xoma (XOMA)

TipRanksAug 13 22:23

Intellia Therapeutics (NTLA) Receives a Buy From J.P. Morgan

TipRanksAug 13 20:23

JP Morgan Maintains Overweight on Intellia Therapeutics, Lowers Price Target to $55

BenzingaAug 12 22:37

Buy Rating Affirmed for Intellia Therapeutics Following Successful Phase II Trials and Strong Cash Reserves

TipRanksAug 12 20:37

Intellia Therapeutics Analyst Ratings

BenzingaAug 10 03:44

RBC Capital Maintains Outperform on Intellia Therapeutics, Lowers Price Target to $54

BenzingaAug 10 03:44

Evercore ISI Reaffirms Their Buy Rating on Intellia Therapeutics (NTLA)

TipRanksAug 9 22:01

RBC Cuts Price Target on Intellia Therapeutics to $54 From $60, Keeps Outperform, Speculative Risk

MT NewswiresAug 9 19:57

Barclays Keeps Their Buy Rating on Intellia Therapeutics (NTLA)

TipRanksAug 9 15:53

Truist Financial Remains a Buy on Intellia Therapeutics (NTLA)

TipRanksJul 31 19:51

Truist Financial Maintains Intellia Therapeutics(NTLA.US) With Buy Rating

Futu NewsJul 31 19:31

Stifel Nicolaus Sticks to Its Buy Rating for Intellia Therapeutics (NTLA)

TipRanksJul 11 21:25